ArticleFrontiers in immunology2024

Clinical and biomarker analyses of hepatic arterial infusion chemotherapy plus lenvatinib and PD-1 inhibitor for patients with advanced intrahepatic cholangiocarcinoma.

YeXing Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.